Program Leader, SPT-300 Program
Company: Seaport Therapeutics
Location: Boston
Posted on: April 13, 2025
|
|
Job Description:
Program Leader, SPT-300 Program at Seaport TherapeuticsSeaport
Therapeutics is seeking a talented Program Leader (PL) to
quarterback the SPT-300 program within Seaport, with significant
executive visibility and potential to make an impact on patients
globally. The SPT-300 program will soon enter into a Phase 2b study
and the PL will lead execution of the current plans within
established timelines and budget while planning for potential
pivotal clinical studies, initial global regulatory filings and
pre-commercial activities. This individual will provide leadership
across the spectrum of drug development activities, ensuring the
achievement of both program and corporate goals. The ideal
candidate will be a strategic and entrepreneurial leader that is
well-versed in drug development. This individual will be a strong
influencer who can integrate multiple perspectives effectively,
align stakeholders across functions and organization levels,
problem solve and achieve the program goals. Ultimately, the PL
position will maximize the SPT-300 program for future clinical and
commercial success in the treatment of depression.This position
requires a presence in the Seaport area of Boston, with a strong
preference for being onsite 3 - 4 days per week to foster
collaboration and effective leadership as the SPT-300 program grows
in complexity and importance. The role will report to the Chief
Executive Officer (CEO).Seaport Therapeutics has a proven strategy
of advancing clinically validated mechanisms previously held back
by limitations that are overcome with its proprietary GlyphTM
technology platform. All the therapeutic candidates in its pipeline
of first and best-in-class medicines are based on the Glyph
platform, which is uniquely designed to enable oral
bioavailability, bypass first-pass liver metabolism and reduce
liver enzyme elevations or hepatotoxicity and other side effects.
Seaport is led by a proven team with a track record in development
of neuropsychiatric medicines and has an extensive network of
renowned scientists, clinicians and key opinion leaders across
neurological specialties. For more information, please visit
Summary of Key Responsibilities
#J-18808-Ljbffr
Keywords: Seaport Therapeutics, Warwick , Program Leader, SPT-300 Program, Other , Boston, Rhode Island
Click
here to apply!
|